Valuation: Omnicell, Inc.

Market Cap 1.68B 1.51B 1.4B 1.27B 2.4B 161B 2.42B 16.87B 6.6B 82.96B 6.32B 6.18B 267B P/E 2026 *
37.5x
P/E 2027 * 36.4x
Enterprise Value 1.68B 1.51B 1.4B 1.27B 2.4B 161B 2.42B 16.87B 6.6B 82.96B 6.32B 6.18B 267B EV / Sales 2026 *
1.36x
EV / Sales 2027 * 1.31x
Free-Float
76.4%
Yield 2026 *
-
Yield 2027 * -
1 day+2.93%
1 week+6.44%
Current month+8.28%
1 month+12.44%
3 months-17.92%
6 months+7.18%
Current year-18.61%
1 week 34.42
Extreme 34.425
37.17
1 month 31.98
Extreme 31.975
37.17
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
55.74
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 2002-09-30
Director of Finance/CFO 56 2025-09-14
President 50 2026-06-30
Director TitleAgeSince
Chairman 68 1992-08-31
Director/Board Member 70 2012-12-31
Director/Board Member 70 2013-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/17/26 Sell

Chairperson

-3,083 0.0068%
8/15/26 Tax

Chief Executive Officer

-12,350 0.0272%
8/15/26 Tax

Chief Administrative Officer

-4,025 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
+2.93%+6.44%+24.06%-14.18% 1.68B
+0.64%-2.15%+26.19%+37.23% 245B
+0.63%-0.00%+9.26%+5.59% 156B
+0.87%+5.21%-0.45%+60.69% 151B
+2.60%+3.40%-54.05%-9.87% 63.53B
+1.38%-0.96%+16.84%+23.56% 49.8B
+1.25%+5.82%-16.06%-17.42% 49.28B
+0.46%+0.02%+25.41%+57.27% 48.3B
-0.09%+4.37%+3.23%+36.99% 47.9B
-0.38%-1.82%+30.54%+72.15% 42.45B
Average +0.88%+2.68%+6.50%+25.20% 85.44B
Weighted average by Cap. +0.72%+1.95%+8.33%+30.92%

Financials

2026 *2027 *
Net sales 1.24B 1.11B 1.03B 936M 1.77B 118B 1.78B 12.4B 4.86B 61.02B 4.65B 4.54B 196B 1.29B 1.15B 1.08B 975M 1.84B 123B 1.85B 12.92B 5.06B 63.55B 4.84B 4.73B 205B
Net income 45.27M 40.53M 37.78M 34.27M 64.64M 4.33B 65.04M 454M 178M 2.23B 170M 166M 7.19B 47.37M 42.4M 39.53M 35.85M 67.62M 4.53B 68.05M 475M 186M 2.34B 178M 174M 7.52B
Net Debt - -
Projected Income Statement - Annual - Omnicell, Inc.
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
26-10-12 US$36.87 +2.93% 459,041
26-10-09 US$35.82 +2.84% 303,072
26-10-08 US$34.83 -1.08% 509,481
26-10-07 US$35.21 -0.71% 570,638
26-10-06 US$35.46 +2.37% 634,245
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Ratings Surperformance© - Omnicell, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
36.87USD
Average target price
57.86USD
Spread / Average Target
+56.92%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Omnicell, Inc.
  1. Stock Market
  2. Stocks
  3. OMCL Stock